Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review</p>
Haiyun Xu, Xiaoyin Zhuang
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 2087-2099
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli, Shivakumar Kolachalam, Biancamaria Longoni, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 238-238
Open Access | Times Cited: 164
The Novel Perspectives of Adipokines on Brain Health
Thomas H. Lee, Kenneth K.Y. Cheng, Ruby L.C. Hoo, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5638-5638
Open Access | Times Cited: 81
Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Gerwyn Morris, Basant K. Puri, Lisa Olive, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 70
Autism Spectrum Disorder: Signaling Pathways and Prospective Therapeutic Targets
Juliana Baranova, Guilherme Dragunas, Mayara C. S. Botellho, et al.
Cellular and Molecular Neurobiology (2020) Vol. 41, Iss. 4, pp. 619-649
Closed Access | Times Cited: 49
Quetiapine for primary insomnia: Consider the risks
Vania Modesto‐Lowe, Agata K. Harabasz, Sophia Walker
Cleveland Clinic Journal of Medicine (2021) Vol. 88, Iss. 5, pp. 286-294
Open Access | Times Cited: 33
Clinical Evaluation of a Novel, Patented Green Coffee Bean Extract (GCB70®), Enriched in 70% Chlorogenic Acid, in Overweight Individuals
Narsingh Verma, Madhukar Mittal, Abbas Ali Mahdi, et al.
Journal of the American Nutrition Association (2024) Vol. 43, Iss. 4, pp. 315-325
Closed Access | Times Cited: 6
Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics
Samantha Álvarez-Herrera, Raúl Escamilla, Óscar Medina‐Contreras, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 37
Epigenetic histone modulations of PPARγ and related pathways contribute to olanzapine-induced metabolic disorders
Yueqing Su, Xuemei Liu, Jiamei Lian, et al.
Pharmacological Research (2020) Vol. 155, pp. 104703-104703
Closed Access | Times Cited: 33
The Rise and Fall of Dopamine: A Two-Stage Model of the Development and Entrenchment of Anorexia Nervosa
Jeff A. Beeler, Nesha S. Burghardt
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 17
Gastrointestinal and liver disease in patients with schizophrenia: A narrative review
Rebecca K Grant, William Brindle, Mhairi Donnelly, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 38, pp. 5515-5529
Open Access | Times Cited: 17
Best Practices, Resources and Innovations: A Mechanistic Review of Nausea and Vomiting Management Options in Cirrhosis
Claudio Tombazzi, Sara Martin
Current Hepatology Reports (2025) Vol. 24, Iss. 1
Open Access
Depression, Angststörungen, bipolare Störung, Schizophrenie, Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung
Johanna Seifert, Stefan Bleich, Roland Seifert
Springer eBooks (2025), pp. 485-535
Closed Access
Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome
Aiperi K. Khasanova, В. С. Добродеева, N. А. Shnayder, et al.
Metabolites (2022) Vol. 12, Iss. 8, pp. 726-726
Open Access | Times Cited: 16
Psychotomimetic compensation versus sensitization
Ari Brouwer, Robin Carhart‐Harris, Charles L. Raison
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 3
Metabolic bariatric surgery, alcohol misuse and liver cirrhosis: a narrative review
Matthew L. Basa, S. Danielle, David Mitchell, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 3
Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice
Bahman Rostama, Megan Beauchemin, Celeste Bouchard, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9362-9362
Open Access | Times Cited: 21
Atypical antipsychotics in multiple sclerosis: A review of their in vivo immunomodulatory effects
Εleni Stamoula, Alexandra Ainatzoglou, Vasileios‐Periklis Stamatellos, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 58, pp. 103522-103522
Closed Access | Times Cited: 14
Impact of 5-HT7 receptor inverse agonism of lurasidone on monoaminergic tripartite synaptic transmission and pathophysiology of lower risk of weight gain
Kouji Fukuyama, Eishi Motomura, Takashi Shiroyama, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112750-112750
Open Access | Times Cited: 13
Social isolation triggers oxidative status and impairs systemic and hepatic insulin sensitivity in normoglycemic rats
María Bové, Adriano Lama, Stefania Schiavone, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112820-112820
Open Access | Times Cited: 13
Olanzapine-induced nonalcoholic fatty liver disease: The effects of differential food pattern and the involvement of PGRMC1 signaling
Zhenyu Zhu, Ting Cao, Hui Chen, et al.
Food and Chemical Toxicology (2023) Vol. 176, pp. 113757-113757
Closed Access | Times Cited: 8
Drug-Associated Liver Injury Related to Antipsychotics
René Zeiss, Susanne Häfner, Carlos Schönfeldt‐Lecuona, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 5, pp. 440-444
Closed Access | Times Cited: 12
Metabolic effects of atypical antipsychotics: Molecular targets
María Fonseca, Francisca Carmo, Fátima Martel
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 12
Open Access | Times Cited: 7
Non‐alcoholic fatty liver disease in a sample of individuals with bipolar disorders: results from the FACE‐BD cohort
O. Godin, Marion Leboyer, Raoul Belzeaux, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 143, Iss. 1, pp. 82-91
Open Access | Times Cited: 17
Concentration-dependent SERS profile of olanzapine on silver and silver-gold metallic substrates
Jamelah S. Al‐Otaibi, Paweł Albrycht, Y. Sheena Mary, et al.
Chemical Papers (2021) Vol. 75, Iss. 11, pp. 6059-6072
Closed Access | Times Cited: 16
Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice
Geng‐Ruei Chang, Po‐Hsun Hou, Wei‐Cheng Yang, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 267-267
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top